A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
Clinical trial NCT05672576 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05672576
- Sponsor
- Viatris Innovation GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-26
- Primary completion
- 2026-10-31
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.